“The Depression and Bipolar Support Alliance (DBSA) is the nation’s leading patient-directed organization focusing on the most prevalent mental illnesses – depression and bipolar disorder. DBSA supports research to promote more timely diagnosis, develop more effective and tolerable treatments and discover a cure.” (http://www.dbsalliance.org/info/aboutdbsa.html; accessed 11/2/06) Corporate Sponsors Include: $150,000+ - Abbott Laboratories
- AstraZeneca Pharmaceuticals
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline
- Janssen Pharmaceutica Products
- Pfizer Inc
- Wyeth Pharmaceuticals
$10,000 - $149,000 - MedEd Resource Group
- Merck & Co., Inc.
$5,000 - $9,999 - Cyberonics, Inc.
- Forest Laboratories
- Neuronetics, Inc.
(http://www.dbsalliance.org/PDF/ANNREPT05.pdf; accessed 11/3/06) The Depression and Bipolar Support Alliance was cited in an article in the New Scientist as having received more than 50 percent of its total funding of $3,522,919 from donations from pharmaceutical/ device companies. (Marshall, Jessica and Aldous, Peter. "Patient groups special: Swallowing the best advice?" New Scientist, 10/27/06, p.1) |
